340 related articles for article (PubMed ID: 33262351)
1. Glycoproteomics-based signatures for tumor subtyping and clinical outcome prediction of high-grade serous ovarian cancer.
Pan J; Hu Y; Sun S; Chen L; Schnaubelt M; Clark D; Ao M; Zhang Z; Chan D; Qian J; Zhang H
Nat Commun; 2020 Dec; 11(1):6139. PubMed ID: 33262351
[TBL] [Abstract][Full Text] [Related]
2. Integrated Proteomic and Glycoproteomic Characterization of Human High-Grade Serous Ovarian Carcinoma.
Hu Y; Pan J; Shah P; Ao M; Thomas SN; Liu Y; Chen L; Schnaubelt M; Clark DJ; Rodriguez H; Boja ES; Hiltke T; Kinsinger CR; Rodland KD; Li QK; Qian J; Zhang Z; Chan DW; Zhang H;
Cell Rep; 2020 Oct; 33(3):108276. PubMed ID: 33086064
[TBL] [Abstract][Full Text] [Related]
3. Site- and structure-specific quantitative N-glycoproteomics study of differential N-glycosylation in MCF-7 cancer cells.
Xue B; Xiao K; Wang Y; Tian Z
J Proteomics; 2020 Feb; 212():103594. PubMed ID: 31759178
[TBL] [Abstract][Full Text] [Related]
4. An integrated proteomic and glycoproteomic approach uncovers differences in glycosylation occupancy from benign and malignant epithelial ovarian tumors.
Li QK; Shah P; Tian Y; Hu Y; Roden RBS; Zhang H; Chan DW
Clin Proteomics; 2017; 14():16. PubMed ID: 28491011
[TBL] [Abstract][Full Text] [Related]
5. Targeted Mass Spectrometry of Longitudinal Patient Sera Reveals LTBP1 as a Potential Surveillance Biomarker for High-Grade Serous Ovarian Carcinoma.
Wenk D; Khan S; Ignatchenko V; May T; Bernardini MQ; Kislinger T
J Proteome Res; 2024 Feb; 23(2):749-759. PubMed ID: 38266179
[TBL] [Abstract][Full Text] [Related]
6. Glycoproteomics: A Balance between High-Throughput and In-Depth Analysis.
Yang Y; Franc V; Heck AJR
Trends Biotechnol; 2017 Jul; 35(7):598-609. PubMed ID: 28527536
[TBL] [Abstract][Full Text] [Related]
7.
Zeng W; Ford KL; Bacic A; Heazlewood JL
Mol Cell Proteomics; 2018 Mar; 17(3):413-421. PubMed ID: 29237727
[No Abstract] [Full Text] [Related]
8. Integrated Proteomic and Glycoproteomic Analyses of Prostate Cancer Cells Reveal Glycoprotein Alteration in Protein Abundance and Glycosylation.
Shah P; Wang X; Yang W; Toghi Eshghi S; Sun S; Hoti N; Chen L; Yang S; Pasay J; Rubin A; Zhang H
Mol Cell Proteomics; 2015 Oct; 14(10):2753-63. PubMed ID: 26256267
[TBL] [Abstract][Full Text] [Related]
9. Precision Structural Interpretation of Site-Specific
Xin M; Xu Y; You S; Li C; Zhu B; Shen J; Chen Z; Shi W; Xue X; Shi J; Sun S
J Proteome Res; 2022 Jul; 21(7):1664-1674. PubMed ID: 35616904
[TBL] [Abstract][Full Text] [Related]
10. Analytical performance of immobilized pronase for glycopeptide footprinting and implications for surpassing reductionist glycoproteomics.
Dodds ED; Seipert RR; Clowers BH; German JB; Lebrilla CB
J Proteome Res; 2009 Feb; 8(2):502-12. PubMed ID: 19072223
[TBL] [Abstract][Full Text] [Related]
11. High-Throughput Analyses of Glycans, Glycosites, and Intact Glycopeptides Using C4-and C18/MAX-Tips and Liquid Handling System.
Chen SY; Clark DJ; Zhang H
Curr Protoc; 2021 Jul; 1(7):e186. PubMed ID: 34232571
[TBL] [Abstract][Full Text] [Related]
12. Multilayered N-Glycoproteome Profiling Reveals Highly Heterogeneous and Dysregulated Protein N-Glycosylation Related to Alzheimer's Disease.
Fang P; Xie J; Sang S; Zhang L; Liu M; Yang L; Xu Y; Yan G; Yao J; Gao X; Qian W; Wang Z; Zhang Y; Yang P; Shen H
Anal Chem; 2020 Jan; 92(1):867-874. PubMed ID: 31751117
[TBL] [Abstract][Full Text] [Related]
13. Characterization of core fucosylation via sequential enzymatic treatments of intact glycopeptides and mass spectrometry analysis.
Cao L; Lih TM; Hu Y; Schnaubelt M; Chen SY; Zhou Y; Guo C; Dong M; Yang W; Eguez RV; Chen L; Clark DJ; Sodhi A; Li QK; Zhang H
Nat Commun; 2022 Jul; 13(1):3910. PubMed ID: 35798744
[TBL] [Abstract][Full Text] [Related]
14. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
[No Abstract] [Full Text] [Related]
15. Identification and characterization of intact glycopeptides in human urine.
Garcia-Marques F; Fuller K; Bermudez A; Shamsher N; Zhao H; Brooks JD; Flory MR; Pitteri SJ
Sci Rep; 2024 Feb; 14(1):3716. PubMed ID: 38355753
[TBL] [Abstract][Full Text] [Related]
16. Identification of candidate biomarkers with cancer-specific glycosylation in the tissue and serum of endometrioid ovarian cancer patients by glycoproteomic analysis.
Abbott KL; Lim JM; Wells L; Benigno BB; McDonald JF; Pierce M
Proteomics; 2010 Feb; 10(3):470-81. PubMed ID: 19953551
[TBL] [Abstract][Full Text] [Related]
17. On-tissue spatially resolved glycoproteomics guided by N-glycan imaging reveal global dysregulation of canine glioma glycoproteomic landscape.
Malaker SA; Quanico J; Raffo-Romero A; Kobeissy F; Aboulouard S; Tierny D; Bertozzi CR; Fournier I; Salzet M
Cell Chem Biol; 2022 Jan; 29(1):30-42.e4. PubMed ID: 34102146
[TBL] [Abstract][Full Text] [Related]
18. Identification of methylated GnTI-dependent N-glycans in Botryococcus brauni.
Schulze S; Urzica E; Reijnders MJMF; van de Geest H; Warris S; Bakker LV; Fufezan C; Martins Dos Santos VAP; Schaap PJ; Peters SA; Hippler M
New Phytol; 2017 Sep; 215(4):1361-1369. PubMed ID: 28737213
[TBL] [Abstract][Full Text] [Related]
19. Glycoproteomic Analysis of Malignant Ovarian Cancer Ascites Fluid Identifies Unusual Glycopeptides.
Miyamoto S; Ruhaak LR; Stroble C; Salemi MR; Phinney B; Lebrilla CB; Leiserowitz GS
J Proteome Res; 2016 Sep; 15(9):3358-76. PubMed ID: 27500424
[TBL] [Abstract][Full Text] [Related]
20. A metabolic labeling approach for glycoproteomic analysis reveals altered glycoprotein expression upon GALNT3 knockdown in ovarian cancer cells.
Sheta R; Woo CM; Roux-Dalvai F; Fournier F; Bourassa S; Droit A; Bertozzi CR; Bachvarov D
J Proteomics; 2016 Aug; 145():91-102. PubMed ID: 27095597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
